This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Oct 5;355(14):1493-5.

doi: 10.1056/NEJMe068191.

A very effective treatment for neovascular macular degeneration

PMID: 17021326
DOI: 10.1056/NEJMe068191

Editorial

A very effective treatment for neovascular macular degeneration

Edwin M Stone. N Engl J Med. 2006.

. 2006 Oct 5;355(14):1493-5.

doi: 10.1056/NEJMe068191.

Author

PMID: 17021326
DOI: 10.1056/NEJMe068191

No abstract available

PubMed Disclaimer

Comment on

Ranibizumab for neovascular age-related macular degeneration.
Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Rosenfeld PJ, et al. N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481. N Engl J Med. 2006. PMID: 17021318 Clinical Trial.
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Clinical Trial.
Age-related macular degeneration.
de Jong PT. de Jong PT. N Engl J Med. 2006 Oct 5;355(14):1474-85. doi: 10.1056/NEJMra062326. N Engl J Med. 2006. PMID: 17021323 Review. No abstract available.

Similar articles

Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration.
Klein RM, Klein RB. Klein RM, et al. Retina. 2007 Nov-Dec;27(9):1163-5. doi: 10.1097/IAE.0b013e31815e9322. Retina. 2007. PMID: 18046218 No abstract available.
Bevacizumab: a compassionate way of doing business?
Spratt A, Ogunbowale L, Franks W. Spratt A, et al. Eye (Lond). 2007 Jun;21(6):890-1; author reply 891. doi: 10.1038/sj.eye.6702776. Epub 2007 Mar 16. Eye (Lond). 2007. PMID: 17363924 No abstract available.
Avastin versus Lucentis: ethical issues.
Wong HC. Wong HC. Retina. 2008 Jul-Aug;28(7):1024-5; author reply 1025. doi: 10.1097/IAE.0b013e318176de5f. Retina. 2008. PMID: 18698312 No abstract available.
Avastin and new treatments for AMD: where are we?
Freeman WR, Falkenstein I. Freeman WR, et al. Retina. 2006 Oct;26(8):853-8. doi: 10.1097/01.iae.0000244722.35073.7c. Retina. 2006. PMID: 17031283 Review. No abstract available.
Bevacizumab: a new way of doing business?
Canning C, Lotery A. Canning C, et al. Eye (Lond). 2006 Sep;20(9):985-7. doi: 10.1038/sj.eye.6702501. Epub 2006 Jul 21. Eye (Lond). 2006. PMID: 16858443 Review.

See all similar articles

Cited by

CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.
Burnight ER, Giacalone JC, Cooke JA, Thompson JR, Bohrer LR, Chirco KR, Drack AV, Fingert JH, Worthington KS, Wiley LA, Mullins RF, Stone EM, Tucker BA. Burnight ER, et al. Prog Retin Eye Res. 2018 Jul;65:28-49. doi: 10.1016/j.preteyeres.2018.03.003. Epub 2018 Mar 22. Prog Retin Eye Res. 2018. PMID: 29578069 Free PMC article. Review.
Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease.
Giacalone JC, Wiley LA, Burnight ER, Songstad AE, Mullins RF, Stone EM, Tucker BA. Giacalone JC, et al. Stem Cells Transl Med. 2016 Feb;5(2):132-40. doi: 10.5966/sctm.2015-0206. Epub 2015 Dec 18. Stem Cells Transl Med. 2016. PMID: 26683869 Free PMC article. Review.
Vascular endothelial cell growth factor-a: not just for endothelial cells anymore.
D'Amore PA. D'Amore PA. Am J Pathol. 2007 Jul;171(1):14-8. doi: 10.2353/ajpath.2007.070385. Am J Pathol. 2007. PMID: 17591949 Free PMC article. No abstract available.
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.
Hurley SF, Matthews JP, Guymer RH. Hurley SF, et al. Cost Eff Resour Alloc. 2008 Sep 11;6:18. doi: 10.1186/1478-7547-6-18. Cost Eff Resour Alloc. 2008. PMID: 18783631 Free PMC article.
Increasing the Efficacy of Gold Nanorod Uptake in Stem Cell-Derived Therapeutic Cells: Implications for Stem Cell Labeling and Optical Coherence Tomography Imaging.
Marquart GW, Stoddard J, Kinnison K, Zhou F, Hugo R, Ryals R, Shubert S, McGill TJ, Mackiewicz MR. Marquart GW, et al. ACS Appl Nano Mater. 2022 May 27;5(5):6995-7008. doi: 10.1021/acsanm.2c00958. Epub 2022 May 16. ACS Appl Nano Mater. 2022. PMID: 39781112 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information